HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert A S Ariëns Selected Research

Factor XIIIa

1/2021Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.
1/2021Nonredundant Roles of Platelet Glycoprotein VI and Integrin αIIbβ3 in Fibrin-Mediated Microthrombus Formation.
1/2016Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.
8/2006Joint linkage and association of six single-nucleotide polymorphisms in the factor XIII-A subunit gene point to V34L as the main functional locus.
8/2002Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert A S Ariëns Research Topics

Disease

29Thrombosis (Thrombus)
07/2021 - 08/2002
8Cardiovascular Diseases (Cardiovascular Disease)
02/2016 - 08/2004
7Venous Thrombosis (Deep-Vein Thrombosis)
01/2021 - 10/2002
6Myocardial Infarction
09/2021 - 07/2003
6Hemorrhage
08/2017 - 08/2010
4Inflammation (Inflammations)
01/2021 - 08/2004
4Vascular Diseases (Vascular Disease)
01/2011 - 09/2002
3Ischemic Stroke
01/2021 - 09/2002
3Pulmonary Embolism
01/2021 - 05/2003
3Stroke (Strokes)
01/2021 - 09/2002
3Abdominal Aortic Aneurysm
01/2014 - 07/2010
2Embolism (Embolus)
01/2021 - 01/2012
2Venous Thromboembolism
01/2021 - 12/2011
2Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
01/2020 - 01/2018
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2016 - 11/2014
2Aneurysm (Aneurysms)
06/2013 - 12/2011
2Thrombophilia
06/2013 - 10/2002
2Intermittent Claudication
04/2009 - 12/2008
2Type 2 Diabetes Mellitus (MODY)
08/2004 - 01/2002
1Bacterial Infections (Bacterial Infection)
03/2022
1Wounds and Injuries (Trauma)
03/2022
1Infections
03/2022
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
07/2021
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2021
1Thromboembolism
01/2021
1COVID-19
01/2021
1Thrombocytopenia (Thrombopenia)
01/2021
1Neoplasms (Cancer)
01/2020
1Hemolysis
01/2020
1Benign Fibrous Histiocytoma (Dermatofibroma)
01/2020
1Diabetes Complications
12/2019
1Obesity
06/2016
1Non-alcoholic Fatty Liver Disease
06/2016
1Liver Diseases (Liver Disease)
06/2016
1Fibrosis (Cirrhosis)
06/2016
1Diabetes Mellitus
11/2014
1Metabolic Diseases (Metabolic Disease)
11/2014
1Activated Protein C Resistance (APC Resistance)
08/2014
1Rupture
12/2011
1Polyps
05/2010
1Peripheral Arterial Disease
12/2008

Drug/Important Bio-Agent (IBA)

35FibrinIBA
03/2022 - 01/2002
15Fibrinogen (Factor I)FDA Link
01/2021 - 05/2003
7Factor XIII (Coagulation Factor XIII)IBA
01/2020 - 03/2002
5Proteins (Proteins, Gene)FDA Link
07/2021 - 08/2002
5Factor XIIIaIBA
01/2021 - 08/2002
4estropipate (Ogen)FDA LinkGeneric
03/2022 - 05/2010
4fibrin fragment D (D-dimer)IBA
01/2021 - 03/2002
4Complement System Proteins (Complement)IBA
01/2021 - 01/2018
4ThrombinFDA Link
06/2016 - 03/2002
4AntigensIBA
06/2011 - 03/2002
3Peptides (Polypeptides)IBA
01/2021 - 08/2014
2von Willebrand FactorIBA
01/2021 - 01/2021
2LigandsIBA
01/2021 - 01/2019
2CholesterolIBA
01/2021 - 12/2008
2AnticoagulantsIBA
11/2020 - 11/2014
2Particulate MatterIBA
07/2016 - 01/2010
2Prothrombin (Factor II)IBA
06/2013 - 03/2002
2Tissue Plasminogen Activator (Alteplase)FDA Link
05/2010 - 03/2002
1Bacterial Proteins (Bacterial Protein)IBA
03/2022
1Anti-Bacterial Agents (Antibiotics)IBA
03/2022
1Biomarkers (Surrogate Marker)IBA
01/2021
1platelet membrane glycoprotein VIIBA
01/2021
1TroponinIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1IntegrinsIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1TransglutaminasesIBA
01/2020
1eculizumabFDA Link
01/2020
1factor XIII subunit AIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
12/2019
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2017
1Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2017
1Hemostatics (Antihemorrhagics)IBA
06/2016
1Alanine (L-Alanine)FDA Link
02/2016
1Leucine (L-Leucine)FDA Link
02/2016
1Glycine (Aminoacetic Acid)FDA LinkGeneric
02/2016
1Valine (L-Valine)FDA Link
02/2016
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2014
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2014
1C-Reactive ProteinIBA
11/2014
1HomocysteineIBA
11/2014
1Fibric Acids (Fibrates)IBA
11/2014
1HDL LipoproteinsIBA
11/2014
1HDL CholesterolIBA
11/2014
1Factor V (Coagulation Factor V)IBA
08/2014
1factor V LeidenIBA
08/2014
1Protein CIBA
08/2014
1antithrombin III-protease complexIBA
06/2013
1antineoplaston A10 (A 10)IBA
12/2011
1Blood Coagulation Factors (Coagulation Factor)IBA
10/2011
1alpha-2-Antiplasmin (alpha 2 Antiplasmin)IBA
06/2011
1PolyphosphatesIBA
05/2010
1PolymersIBA
05/2010
1PlasminogenIBA
05/2010
1FibrinolysinFDA Link
05/2010

Therapy/Procedure

5Therapeutics
03/2022 - 07/2003
2Thrombectomy
01/2021 - 01/2021
1Thrombolytic Therapy
01/2021
1Endovascular Aneurysm Repair
06/2013